ID
12471
Beskrivning
The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462
Länk
https://clinicaltrials.gov/ct2/show/NCT01294462
Nyckelord
Versioner (2)
- 2015-07-28 2015-07-28 -
- 2015-11-21 2015-11-21 -
Uppladdad den
21 november 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462
Eligibility criteria
- StudyEvent: ODM
Beskrivning
Exclusion criteria
Beskrivning
Index event is an acute complication of percutaneous coronary intervention
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1532338
Beskrivning
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Datatyp
boolean
Alias
- UMLS CUI-1
- C1532338
Beskrivning
Oral anticoagulation therapy that cannot be stopped
Datatyp
boolean
Alias
- UMLS CUI-1
- C0003281
Beskrivning
The conditions associated with increased risk of bradycardiac events
Datatyp
boolean
Alias
- UMLS CUI-1
- C0428977
Similar models
Eligibility criteria
- StudyEvent: ODM
C1532338 (UMLS CUI [1,2])